WPRIM Management System> DCMS> Journal of Korean Breast Cancer Society> > 4

Volume: 4

1. Immediate Free TRAM Flap Reconstruction after Mastectomy in Breast Cancer Patients. Page:93—97
2. Combined Peritumoral and Subareolar Injection of Blue Dye Improves Sentinel Lymph Node Localization Rates. Page:87—92
3. Clinical Significance of Rotter's Nodes in Patients with Breast Carcinomas. Page:80—86
4. The Clinical Significance and Prognosis of Korean Young Age (younger or 35 year old) onset Breast Cancer. Page:74—79
5. The Impact of Patient Age upon Locoregional and Systemic Failures after Breast Conservation Therapy: Comparison of the Results from the Groups above and below 35 Years. Page:68—73
6. Breast Cancer in Third Decade-Does It Really Have a Poor Prognosis?. Page:63—67
7. Paget's Disease of the Breast. Page:57—62
8. Clinical Analysis of Stage I and II Breast Cancer. Page:50—56
9. Clinical Analysis of Breast Cancer Surgeries in Korea. Page:43—49
10. A Study on Modified Triple Test for Palpable Breast Mass. Page:37—42
11. Expression Pattern of Glucose Transporter GLUT1 Protein & Its Correlation with Prognostic Factors in Breast Cancer. Page:161—166
12. Expression Pattern of Glucose Transporter GLUT1 Protein & Its Correlation with Prognostic Factors in Breast Cancer. Page:161—166
13. The Expression of High Mobility Group I (Y) Proteins in Human Breast Cancer. Page:1—5
14. Loss of Expression of the PTEN Gene Product in the Infiltrating Ductal Carcinoma of the Breast and Its Relationship with Clinicopathologic Factors. Page:6—11
15. Significance on the Expression of Cyclin, MIB-1 in Benign and Malignant Papillary Lesion of the Breast. Page:12—19
16. The Antiproliferating Effect of Diallyl Disulfide from Garlic on the Human Breast Cancer Cell Line (MCF-7). Page:20—30
17. Use of the Triple Test for the Patients with Palpable Breast Masses. Page:31—36
18. Prognosis of GLUT1 Expression in Human Breast Carcinoma. Page:167—171
19. Relationship between Cathepsin D Expression and Other Prognostic Factors in Primary Breast Cancer. Page:172—178
20. Apoptosis Related Protein Expressions in Immunohistochemical Staining Using Tissue Microarrays of Breast Cancer. Page:179—184
21. The Significance of Cytokeratin-20 Detection in Peripheral Blood and Bone Marrow of Breast Cancer Patients. Page:185—191
22. The Relationship between Plasminogen Acti- vator Inhibitor-1 and Bone Marrow Microme- tastases in Breast Cancer. Page:192—197
23. A Pychosocial Support Program for Women with Primary Breast Carcinoma. Page:99—105
24. A Pychosocial Support Program for Women with Primary Breast Carcinoma. Page:99—105
25. Causes and Sexual Hormonal Changes in Patients with Gynecomastia. Page:106—110
26. Causes and Sexual Hormonal Changes in Patients with Gynecomastia. Page:106—110
27. Reduction Surgery for Giant Breast. Page:111—114
28. Reduction Surgery for Giant Breast. Page:111—114
29. Incidence and Characteristics of Thyroid Nodules in Patients with Breast Cancer. Page:115—119
30. Incidence and Characteristics of Thyroid Nodules in Patients with Breast Cancer. Page:115—119
31. Micrometastasis of Sentinel Lymph Node in Breast Cancer. Page:120—127
32. Micrometastasis of Sentinel Lymph Node in Breast Cancer. Page:120—127
33. Clinical Value of CEA, CA15-3 and TPS in Breast Cancer. Page:136—143
34. Clinical Value of CEA, CA15-3 and TPS in Breast Cancer. Page:136—143
35. Expression of p53, c-erbB2, bcl-2, Cathepsin D in Infiltrating Ductal Cancer of the Breast. Page:144—151
36. Expression of p53, c-erbB2, bcl-2, Cathepsin D in Infiltrating Ductal Cancer of the Breast. Page:144—151
37. Correlation between p53 and MIB1 Index Expression of Primary Tumor and Metastatic Lymph Node in Breast Cancer. Page:152—160
38. Correlation between p53 and MIB1 Index Expression of Primary Tumor and Metastatic Lymph Node in Breast Cancer. Page:152—160
39. Factors Influencing the Recurrence of Breast Cancer Following Modified Radical Mastectomy. Page:128—135
40. Factors Influencing the Recurrence of Breast Cancer Following Modified Radical Mastectomy. Page:128—135